Category: Mazor Robotics Ltd.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
Medical device company Mazor Robotics drums up $15 million in a private placement, aiming to get its share traded on a U.S. stock exchange.
Mazor Robotics (PINK:MZRTF) wants to get on a major U.S. stock exchange, saying it's raised $15 million in a private placement to that end.
The Caesarea, Israel-based medical device company said the 2-tranche round is divided among "a group of institutional and accredited investors" led by Oracle Investment Management.
Mazor Robotics wins FDA clearance to extend its Renaissance robotic platform into brain surgery.
Mazor Robotics (PINK:MZRTF) won FDA clearance extending use of its Renaissance robotic system into brain surgery, the company announced this week.
Orthopedics bellwether Biomet's 2nd-quarter preliminary sales numbers are up 4%, sending other ortho stocks up on Wall Street; also, quarterly results for Analogic; Angeion; Cantel Medical; Cyberonics; Hamilton Thorne; LED Medical; Mauna Kea Technologies; Mazor Robotics; Optos; Rectractable Technologies; Sectra; SeraCare; Sirona Dental; Solos Endoscopy; Synergetics; Synovis; and World Heart Corp.
Shares of orthopedic device makers are up this morning after bellwether Biomet Inc. reported preliminary sales numbers indicating 3.8% growth for its fiscal second quarter.
Mazor's next-gen robot expands potential spinal applications for machine-guided surgery.
Mazor Robotics Ltd. (TASE:MZOR) unveiled its new Renaissance device, the next generation of its spinal robotic surgical guidance systems technology, which extend potential applications to more complex spine surgeries.
The new system is built on the core of the previous generation SpineAssist technology, which has been successfully used in more than 2,000 surgeries worldwide, accurately placing more than 12,000 implants, according to company officials.